3M $7.35 Billion PFAS Settlement 2026, Who Qualifies, How Much Could Victims Receive and When?

3M has agreed to a $7.35 billion settlement to resolve about 99% of its current PFAS-related personal injury claims. It could provide compensation to 115,000–120,000 people who allege serious illness after exposure to PFAS chemicals found in firefighting foam and other sources.

3M announced the agreement on November 3, 2026. It is one of the biggest developments in the long-running Aqueous Film-Forming Foams (AFFF) Products Liability Litigation, MDL No. 2873, in the U.S. District Court for the District of South Carolina. The company committed a nominal $7.35 billion over nine years (2026–2034), with a present value of about $5.8 billion. It expects to record a pretax charge of about $5.8 billion in the fourth quarter of 2026.

The settlement covers six medical conditions: kidney cancer, testicular cancer, liver cancer, thyroid cancer, ulcerative colitis and thyroid disease. Potential participants include people alleging direct PFAS exposure, such as through firefighting foam, and people alleging exposure through contaminated drinking water.

However, this is not an open public class settlement where anyone diagnosed with cancer can submit a claim online. It is a private, opt-in agreement that mainly covers plaintiffs already involved in the AFFF MDL, plus related personal injury claims outside it. It sets up a structured process for identifying claimants, confirming eligibility and allocating compensation.

Two days away: November 13, 2026. U.S. District Judge Richard M. Gergel’s November 4 order requires attorneys for eligible claimants to submit their clients’ information by that date. It is a court deadline for lawyers, not a public claim-form deadline.

3M denies wrongdoing and has not admitted that its products caused anyone’s illness. No individual payout amounts have been announced, and the largest company payments start in 2028 and depend on the agreement’s conditions.

3M PFAS Settlement 2026: Quick Facts

Detail	Latest verified information
Company	3M Company
Settlement announced	November 3, 2026
Nominal financial commitment	Up to $7.35 billion over nine years
Present value	About $5.8 billion
Potential eligible plaintiffs	115,000–120,000
Share of current claims addressed	About 99%, according to 3M
Litigation	In re: Aqueous Film-Forming Foams Products Liability Litigation
MDL	No. 2873
Court	U.S. District Court, District of South Carolina
Judge	Richard M. Gergel
Eligible medical conditions	Six specified diseases
Exposure types	Direct PFAS exposure and contaminated drinking water
Claimant identification deadline	November 13, 2026 (Case Management Order No. 39)
Settlement participation	Individual election and release required
Official settlement website	None launched or reported as of November 11, 2026. Official sources: 3M’s settlement announcement, the SEC-filed Master Settlement Agreement and the court’s AFFF MDL portal (used by counsel)
Claims administrator	Not named in the reporting reviewed
Public online claim form	None established for unrestricted public registration
Fixed individual payout	Not announced
Initial company contribution	$50 million in 2026
Company payments in 2027	None scheduled
Main company funding	2028–2033
Final scheduled funding period	Through 2034
Admission of liability	No

What Did 3M Announce on November 3, 2026?

3M announced a master settlement agreement with the lawyers negotiating for plaintiffs in the federal AFFF litigation, and filed it with the SEC (Form 8-K, November 4). The company committed a nominal maximum of $7.35 billion over nine years. Because much of the money is paid in later years, 3M puts the present value at about $5.8 billion. Reporting says about 120,000 plaintiffs have filed personal injury claims since 2018.

Does the agreement cover all PFAS lawsuits?

No. It is designed to resolve most current personal injury claims against 3M involving six specified conditions. It also includes mechanisms for remaining and future claims, inside and outside the MDL. It does not automatically settle lawsuits against DuPont, Chemours, Tyco, BASF or other PFAS-related defendants. It also does not settle every environmental-contamination or property-damage case.

Who Qualifies for the 3M $7.35 Billion PFAS Settlement?

The agreement defines an eligible claimant as someone with a PFAS-related personal injury claim for a qualifying medical condition and PFAS exposure. It recognizes direct-exposure and drinking-water claims. A case may be pending in the federal MDL or another court, and some represented but unfiled claims fall within the identification process.

Meeting the general definition does not guarantee payment. Participants must satisfy the agreement’s enrollment, documentation and claims-review requirements. Claims dismissed with prejudice before November 3, 2026 are excluded from the eligible-claimant definition. The 115,000–120,000 figure is 3M’s estimate of plaintiffs eligible to participate, not a count of approved recipients.

Which six medical conditions qualify?

Medical condition	Included under the agreement?
Kidney cancer	Yes
Testicular cancer	Yes
Liver cancer	Yes
Thyroid cancer	Yes
Ulcerative colitis	Yes
Thyroid disease	Yes
High cholesterol alone	Not an eligible injury
Pregnancy-induced hypertension alone	Not an eligible injury
Other illnesses not listed	Not qualifying under this agreement

The list is specific to this settlement and is not a complete scientific assessment of every possible PFAS health effect. The CDC’s Agency for Toxic Substances and Disease Registry (ATSDR) reports research associations between certain PFAS and several health outcomes, and the strength of the evidence varies by condition and chemical. A qualifying diagnosis alone does not show that a particular person’s illness was caused by a 3M product.

Do Firefighters and Military Veterans Qualify for the 3M PFAS Settlement?

Potentially. For decades, aqueous film-forming foam (AFFF) was used to put out fires involving flammable liquids, including at:

• Military bases.
• Civilian and military airports.
• Fire departments.
• Industrial facilities.
• Firefighting training areas.

Many claimants are firefighters, military personnel and others exposed during training or emergency response, or through contaminated water near bases and facilities where AFFF was used. Being a firefighter or a veteran does not by itself establish eligibility. The claimant must also meet the medical, exposure, litigation and documentation requirements.

For the broader history of firefighting-foam lawsuits, see AFFF Firefighting Foam Lawsuit April 2026, 15,222 Cases Pending, Bellwether Trial Pulled, Global Settlement Expected. That earlier article predates the November settlement.

Can Residents Exposed Through Contaminated Drinking Water Qualify?

Potentially. The agreement recognizes a separate category of claimants alleging PFAS exposure through drinking water, including public water systems and private wells. People who lived near military installations, airports, industrial facilities or other contaminated sites may have relevant exposure histories.

Living where PFAS has been detected does not by itself establish a compensable claim. A claimant generally must show the required diagnosis and enough exposure under the settlement’s allocation procedures. The settlement concerns qualifying personal injuries, not just contamination in a community’s water. (Separate public-water-system settlements are covered below.)

How Much Money Will Each Person Receive From the 3M PFAS Settlement?

No verified individual payout schedule has been announced. The agreement does not set one amount for kidney cancer, thyroid cancer or any other condition. Eligible claims are evaluated through an allocation system. According to the master settlement agreement, the claims administrator will consider:

• The qualifying medical diagnosis.
• Whether the claimant alleges direct exposure or drinking-water exposure.
• The duration and degree of relevant PFAS exposure.
• Supporting medical and exposure documentation.
• The scoring criteria in the allocation procedures.

Each approved claimant receives a final score that is used to calculate an allocated award. Participants may receive estimated allocation information before they decide whether to participate. The agreement also sets separate processes for enhancement awards and extraordinary needs.

Will cancer patients receive more than people with thyroid disease?

Not necessarily in every case. Different conditions and exposure histories may produce different scores. The allocation procedures, not a published payout chart, control the calculation.

Is there a guaranteed $100,000 or $500,000 payment?

No. The agreement has not published a guaranteed amount per person. Earlier law-firm estimates of AFFF case values should not be presented as confirmed awards under this agreement. Dividing $7.35 billion by 120,000 potential claimants (about $61,000) gives a misleading average. The total includes contingent funding, administration costs and other obligations, and individual allocations depend on claim review.

What can reduce a claimant’s net payment?

Attorney fees, common-benefit assessments in the MDL and liens can reduce what a claimant ultimately receives. Liens can include Medicare, Medicaid, private-insurer or ERISA plan reimbursement claims. For Medicare beneficiaries, the Medicare Secondary Payer Act (42 U.S.C. § 1395y(b)(2)) requires settlement payors and claimants to deal with Medicare’s conditional payments, and settlements are reported to Medicare under federal reporting rules. These costs vary by person, and no standard deduction figure has been published.

Are PFAS settlement payments taxable?

Under 26 U.S.C. § 104(a)(2), damages received on account of personal physical injuries or physical sickness are generally excluded from gross income, but the treatment of any punitive damages, interest or amounts for non-physical claims can differ. That is general information, not tax advice, and claimants should ask a tax professional about their own situation.

When Will 3M PFAS Settlement Payments Begin?

3M’s published payment schedule runs through 2034, with the largest installments beginning in 2028 if the settlement’s participation and other conditions are met. Roughly 20% is due in the final two years, and the structure lines up with 3M’s other legacy settlement obligations.

Year	Published company payment structure
2026	Initial $50 million payment
2027	No company payment scheduled
2028	First major installment of $1.045 billion, no earlier than January 15
2029	Second $1.045 billion installment, plus possible contingent payments
2030	Third $1.045 billion installment, plus possible contingent payments
2031	Fourth $1.045 billion installment
2032	Fifth $1.045 billion installment
2033	Sixth $1.045 billion installment
2034	Potential final reserve funding and remaining distributions

The six main installments total $6.27 billion. Adding the $50 million initial payment gives $6.32 billion. The remaining roughly $1.03 billion reflects the conditional components described below (up to $680 million reserve, up to $250 million in participation-based payments and $100 million in conditional bonus payments), which brings the potential commitment to $7.35 billion.

Will claimants receive checks in 2026?

No verified schedule for individual checks in 2026 exists. The initial $50 million supports settlement implementation and is part of the overall financial structure. It is not a fund available for immediate public distribution.

Will everyone receive their money in 2028?

No. The company’s payment schedule is not an individual payout schedule. The agreement sets payment priorities and provides for distributions as funds become available, so claimants may be paid at different stages depending on the allocation process, funding and other requirements. No universal check-mailing date has been set.

What Is the November 13, 2026 Deadline in the 3M PFAS Settlement?

This is the most time-sensitive development. On November 4, Judge Gergel entered Case Management Order No. 39, the Identification Order. It directs attorneys for eligible personal injury claimants to identify their clients through the AFFF MDL claims portal by November 13, 2026. It applies to represented eligible claimants whether their cases are filed or not, and it sets procedures for certain people representing themselves in existing MDL cases.

Is November 13 the public settlement claim deadline?

No. The deadline is for the court’s process of identifying potential claimants. It is not an open online deadline for everyone who believes they were exposed to PFAS. Being identified also does not mean the person has agreed to participate.

What happens after November 13?

The order sets further deadlines for certain identified claims. Lawyers may have to file previously unfiled cases within ten days after the identification deadline and complete specified plaintiff fact sheets within fourteen days, subject to the order’s exceptions. Failing to comply may affect whether a claimant can participate. Anyone already represented in AFFF litigation should contact their attorney promptly to confirm the identification information was submitted.

How Do Eligible Plaintiffs Join the 3M PFAS Settlement?

This is an opt-in personal injury settlement, not a conventional class action in which everyone is included unless they opt out. Because the participants are individual clients, it is also not governed by the Rule 23(e) class-settlement approval process. Lawyers settling many clients’ claims together must get each client’s informed consent, a rule reflected in ABA Model Rule 1.8(g) and in state versions of it. The process has several stages:

1. Claimant identification. Eligible claimants are identified through the court-approved process, usually by their attorneys.
2. Estimated award information. The administrator provides eligible claimants with estimated allocation information.
3. Participation election. Claimants choose to participate, to decline and end their litigation, or to decline and keep litigating.
4. Release and dismissal documents. Participants generally sign a broad legal release and provide dismissal documents.
5. Complete claim package. Participants submit the required medical, exposure and other supporting information.
6. Review and allocation. The administrator scores the claim and calculates an award. The agreement includes procedures to correct certain deficiencies and to appeal specified scoring errors.

There is no unrestricted public settlement website offering immediate registration and guaranteed payments. The AFFF MDL portal is for litigation administration and court-required submissions, not an ordinary consumer cash-claim form. If a claims administrator launches an official settlement website later, it will be the place to confirm participation steps, and readers should use only the website linked from the court’s docket or an attorney.

Does Accepting the 3M PFAS Settlement Waive Future Lawsuit Rights?

Yes, and that is a major consideration. The master settlement agreement requires participating claimants to sign a comprehensive release of specified PFAS-related personal injury and related claims against the released parties, and it requires dismissal of covered claims with prejudice, which generally bars bringing the same claim again. The release may reach future injury-related claims within its defined scope. The settlement has procedures for certain family members, derivative claims and the estates of deceased plaintiffs. Participation elections are binding, subject to limited exceptions, so claimants should understand the release before electing to participate.

What Happens If Someone Refuses the 3M PFAS Settlement?

The November 4 Case Management Order No. 40 sets procedures for claimants who keep litigating against 3M. It imposes detailed requirements on medical records, exposure evidence, statutes of limitations and expert reports. For example, covered litigating plaintiffs generally face a 120-day deadline to serve case-specific expert reports, measured from the applicable triggering event, and noncompliance can lead to dismissal. The judge also stayed personal injury proceedings against 3M in the MDL while settlement implementation proceeds, except for the procedures in the orders. Claims against other defendants are not automatically stayed by that 3M-specific order. A claimant thinking about declining should get advice about how these requirements affect the case.

What defenses has 3M raised in AFFF litigation?

Defendants in AFFF cases have argued, among other things, that causation is not proven for each plaintiff and that products made to military specifications fall under the government contractor defense (see Boyle v. United Technologies Corp., 487 U.S. 500 (1988)). Whether those arguments would succeed was not decided by the settlement, since 3M denies liability.

Do statutes of limitations still matter?

Yes. State law sets the filing deadlines for personal injury claims, and 42 U.S.C. § 9658 (CERCLA § 309) can set a federal discovery-based start date for limitations periods in some hazardous-substance injury cases. The November 2026 agreement does not reopen expired claims or extend every deadline.

What Is the $680 Million Reserve Fund in the 3M Settlement?

3M’s total commitment includes a possible reserve fund of up to $680 million. It is not a separate $680 million public settlement for people who have not joined the litigation. It is part of the master settlement’s financial structure and depends on specific conditions, with potential reserve payments through 2034. The funds may become available to participating claimants under the allocation procedures. The agreement also includes up to $250 million in participation-based payments and $100 million in conditional bonus payments, and amounts actually paid depend on whether the contractual conditions are met. Reporting also describes payments that are contingent on plaintiffs joining and a court order setting evidentiary and timing requirements for plaintiffs who may litigate later.

Is the 3M $7.35 Billion Settlement Final?

3M and plaintiffs’ negotiating counsel have signed a binding settlement agreement, but implementation is conditional. The agreement has participation thresholds, and if participation falls below specified levels, 3M may have the right to terminate it. The company said it was prepared to keep defending the litigation if the conditions are not met. Because the total depends on participation and the agreement has walk-away rights, the amount actually paid could be lower than the $7.35 billion headline if fewer claimants join than projected. Readers should distinguish:

• A signed settlement agreement: Confirmed November 3.
• Successful enrollment of eligible claimants: Still being implemented.
• Final individual awards: Not yet determined.
• Actual payments to plaintiffs: No general schedule announced.

The agreement is not a court-approved consumer class settlement with an automatic nationwide distribution.

Is This the Same as 3M’s Earlier Public Water System Settlement?

No. 3M agreed in 2023 to resolve many public water suppliers’ PFAS contamination claims, and the court gave final approval in March 2024. That agreement had a discounted present value of about $10.3 billion, with total nominal payments of up to $12.5 billion over 13 years. Its purpose was to help eligible public water systems address PFAS contamination. The November 2026 agreement addresses qualifying individual personal injury claims.

Key issue	Earlier water-provider settlement	New personal-injury settlement
Main beneficiaries	Eligible public water systems	Qualifying personal injury claimants
Principal purpose	Water testing and contamination-related costs	Compensation for alleged illnesses
Agreement announced	2023	November 3, 2026
Nominal commitment	About 10.5B–12.5B	Up to $7.35B
Ordinary consumer claim form	No	No unrestricted public claim form
Legal structure	Public-water class settlement	Opt-in personal-injury agreement

Separate settlements with states, such as New Jersey, also exist and are different from this personal injury resolution. Other companies have resolved their own PFAS environmental claims. For example, DuPont, Chemours and Corteva $590 Million PFAS Settlement, What It Means for North Carolina — N.C. ex rel. Jackson v. DuPont, No. 2020 CVS 5612 concerns compensation and environmental obligations for North Carolina and local governments. It is unrelated to eligibility under the new 3M personal injury agreement.

What Federal Laws and Standards Affect PFAS Claims?

PFAS (per- and polyfluoroalkyl substances) are often called “forever chemicals.” Several federal frameworks shape the wider litigation, though none changes who qualifies under this private agreement:

• Safe Drinking Water Act (42 U.S.C. § 300f et seq.). EPA adopted enforceable drinking-water limits for PFOA and PFOS in 2024. Readers should check the current limits and compliance dates, which are subject to change.
• CERCLA (42 U.S.C. § 9601 et seq.). EPA has designated PFOA and PFOS as hazardous substances, which affects cleanup liability, and § 309 (42 U.S.C. § 9658) affects limitation periods.
• MDL procedure (28 U.S.C. § 1407). Centralizes related federal cases for pretrial proceedings, which is why one judge in South Carolina oversees the AFFF cases.

Does the 3M Settlement Include International PFAS Lawsuits?

No worldwide settlement has been announced. The agreement focuses on claims tied to the U.S. federal AFFF litigation and related personal injury claims, and separate international suits may continue. For example, Australia’s $1.4 Billion PFAS Lawsuit Against 3M, What Happened at 28 Defense Bases Commonwealth of Australia v. 3M Company and 3M Australia Pty Ltd, Federal Court of Australia concerns another country’s environmental contamination allegations. The U.S. personal injury agreement does not resolve that case.

3M PFAS Settlement Timeline

Date	Development
December 7, 2018	Federal AFFF multidistrict litigation established
June 2023	3M announces a separate public-water supplier settlement
March 2024	Court grants final approval to the public-water agreement
August 2025	Court removes a previously scheduled personal injury bellwether trial
November 3, 2026	3M signs the $7.35 billion personal injury master settlement agreement
November 4, 2026	3M files the agreement with the SEC
November 4, 2026	Judge Gergel issues Case Management Orders 39 and 40
November 13, 2026	Deadline for counsel and applicable self-represented claimants to submit identification responses
2026	Initial $50 million company contribution
2027	No company payment scheduled
January 2028 onward	Main funding installments begin if agreement conditions are met
2029–2034	Additional scheduled and conditional funding

Frequently Asked Questions About the 3M $7.35 Billion PFAS Settlement

Is the 3M $7.35 billion PFAS settlement real?

Yes. 3M announced the agreement on November 3, 2026 and filed the master settlement agreement with the SEC.

How many people qualify?

3M estimates about 115,000–120,000 plaintiffs are eligible to participate. That is not a count of approved compensation recipients.

Which cancers qualify?

Kidney cancer, testicular cancer, liver cancer and thyroid cancer are expressly listed.

Does thyroid disease qualify without cancer?

Yes. Thyroid disease is separately listed, although a diagnosis alone does not guarantee payment.

Does ulcerative colitis qualify?

Yes. Ulcerative colitis is expressly included.

Do all people with PFAS in their blood qualify?

No. PFAS exposure is widespread, and a blood test does not show what caused an individual illness (see CDC/ATSDR’s guidance on PFAS blood testing). The agreement requires a qualifying personal injury claim and documentation.

Can firefighters apply?

Potentially, if they meet the injury, exposure and litigation requirements.

Can military veterans qualify?

Potentially. The agreement covers qualifying direct-exposure claims, but military service alone does not establish eligibility.

Can people exposed through drinking water qualify?

Yes, if they meet the settlement’s drinking-water exposure and medical requirements.

How much will each cancer patient receive?

No verified individual payout chart has been published.

Is everyone receiving $61,000?

No. Dividing the nominal maximum by the estimated number of claimants gives a misleading average that ignores allocation criteria, contingencies, costs and differences between claims.

When will settlement checks arrive?

No individual payment date has been announced. Major company funding begins no earlier than 2028 under the published schedule.

Can new claimants sign up online?

There is no unrestricted public enrollment process and no official settlement website has been reported. Existing claimants should work through counsel or the court process. Be cautious about anyone charging fees or promising payments under this settlement to people who never filed a claim.

What happens if I miss November 13?

That is the court’s claimant-identification deadline, mainly affecting attorneys and applicable self-represented litigants. Anyone worried about an existing claim should contact their attorney immediately.

Does 3M admit causing cancer?

No. The company denies wrongdoing and says the settlement is not an admission of liability.

Does this resolve claims against DuPont?

No. The agreement covers claims against 3M and specified released parties. Litigation against other defendants is not automatically resolved.

Can 3M cancel the settlement?

The agreement has participation thresholds, and 3M may have walk-away rights if participation falls below specified levels.

Is the settlement money taxable?

Damages for personal physical injuries are generally excluded from income under 26 U.S.C. § 104(a)(2), with exceptions. Ask a tax professional about your situation.

What Should Potential Claimants Do Now?

People already represented in AFFF or PFAS personal injury litigation should contact their attorneys to confirm compliance with the November 13 identification order. Potential claimants without a lawyer should know that the settlement does not create an unrestricted new public application process.

Anyone considering a possible PFAS-related claim should preserve medical records, diagnosis dates, employment or military service records, exposure histories and any drinking-water test results. The deadline for any new or separate lawsuit depends on the facts, state law and court orders. The November 2026 agreement does not reopen expired claims or extend every statute of limitations.

The Bottom Line

The November 3, 2026 agreement is a major development in the AFFF personal injury litigation. 3M has committed up to $7.35 billion over nine years to resolve about 99% of its current PFAS-related personal injury claims. Six medical conditions are covered, and roughly 115,000–120,000 plaintiffs may be eligible to participate.

The agreement is not a public cash settlement open to everyone exposed to PFAS. Claimants must satisfy the participation and documentation requirements, individual payouts are undetermined, and the largest company installments are scheduled for 2028–2033. The immediate development is the November 13, 2026 claimant-identification deadline set by the federal court. The next questions are how many eligible plaintiffs enroll, whether the participation conditions are met and how individual awards are calculated.

Primary Court Documents and Official Sources

1. 3M — November 3, 2026 Settlement Announcement. Official company announcement, the $7.35 billion commitment and the estimated claimant population.
2. 3M — SEC Form 8-K Filed November 4, 2026. Material settlement disclosure and participation conditions.
3. Master Settlement Agreement — SEC Exhibit 10.1. Official agreement defining eligible injuries, registration, releases, allocations and payment obligations.
4. Official Settlement Payment Schedule — SEC Exhibit 10.1A. Funding dates, principal installments and conditional payments.
5. Case Management Order No. 39 — November 4, 2026 (PDF). November 13 claimant-identification deadline.
6. Case Management Order No. 40 — November 4, 2026 (PDF). Requirements for continuing personal injury claims against 3M.
7. 3M — September 2026 Quarterly SEC Report. Earlier public-water settlement and litigation history.
8. Reuters — 3M Commits $7.35 Billion to Resolve PFAS Personal-Injury Claims. November 2026 reporting.
9. Wisconsin Public Radio — 3M Reaches $7.35B Settlement Over PFAS. November 5, 2026 reporting on the November 13 deadline and attorney comments.
10. CDC/ATSDR — PFAS Health Effects. Scientific background and limits of PFAS health-effect findings.
11. CDC/ATSDR — Testing for PFAS. Limits of PFAS blood testing.

Verification note: Settlement eligibility and timing reflect the filed agreement and court orders as reported through November 11, 2026. No public individual award schedule, claims administrator, official settlement website or unrestricted consumer claim form has been verified. The $7.35 billion figure is the maximum nominal commitment, subject to participation and other contractual conditions.

Disclaimer: AllAboutLawyer.com is an independent legal-information website, not a law firm or medical practice. This article is general legal reporting and information, not legal or medical advice. Individual claims require evaluation under the agreement and applicable law. A diagnosis or exposure history does not automatically establish causation or entitlement to compensation.

Researched and written by Israr Ahmad, legal content researcher and founder of AllAboutLawyer.com. All facts verified against 3M’s November 3, 2026 announcement and SEC filings as reported, Reuters and other news coverage, and the November 4 court orders as described, as of November 11, 2026. Last Updated: November 11, 2026.